Fierce Pharma

DECEMBER 4, 2024

AstraZeneca’s Daiichi Sankyo-partnered antibody-drug conjugate Enhertu has made it onto China’s national insurance program despite the star med being a part of an ongoing investigation in the count | AstraZeneca’s Daiichi Sankyo-partnered antibody-drug conjugate Enhertu has made it onto China’s national insurance program despite the star med being a part of an ongoing investigation in the country.

Insurance 316

Insurance 316

pharmaphorum

DECEMBER 4, 2024

Genmab has licensed another anti-glycan antibody for cancer from UK biotech Scancell as it continues to expand its in-house pipeline.

129

129

Fierce Pharma

DECEMBER 4, 2024

Merus’ week keeps getting better. | The FDA had originally pushed its decision back by three months after a November manufacturing-related delay.

FDA 299

FDA Manufacturing 299

MedCity News

DECEMBER 4, 2024

Eli Lilly obesity drug Zepbound led to 47% greater relative weight loss compared to Wegovy in a head-to-head clinical trial. The results could help Lilly differentiate its product from Novo Nordisk’s in the increasingly competitive market of obesity medications. The post Eli Lilly’s Zepbound Leads to Greater Weight Loss vs. Novo Nordisk Drug in Head-to-Head Test appeared first on MedCity News.

Leads 119

Leads Competition Medical Marketing 119

Advertisement

What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.

Sales Management

Fierce Pharma

DECEMBER 4, 2024

Amid a multi-year, multibillion-dollar spending spree to scale its global manufacturing capacity, Novo Nordisk is laying down fresh foundations at its old stomping grounds in Denmark to bolster a c | Novo will invest 2.9 billion Danish kroner (roughly $409 million) to construct a new, 53,000-square-meter quality control laboratory in Hillerød, Denmark.

Manufacturing 289

Manufacturing 289

MedCity News

DECEMBER 4, 2024

The Glp-1 battle heats with new preliminary data from Eli Lilly showing that patients using its weight loss drug Zepbound lost more weight on average in 72 weeks than those on Novo Nordisk’s Wegovy. The post Video: Battle of the Bulge – Wegovy vs. Zepbound appeared first on MedCity News.

Patients 114

Patients Biopharma 114

MedCity News

DECEMBER 4, 2024

Fello’s $10.4 million raise includes a seed investment from Glen Tullman’s 62Ventures, The Capital Factory Fellowship Fund, Katalyst Capital and Offline Ventures. The post Peer Support Platform Fello Secures $10.4M To Combat Loneliness Epidemic appeared first on MedCity News.

119

119

Fierce Pharma

DECEMBER 4, 2024

With the purchase of a plant in the Czech Republic, Novo Nordisk is saying “jak se máš” to hundreds of new employees—and expanding its production footprint along the way. | Novavax is selling its 150,000-square-foot recombinant protein facility in Bohumil, Czech Republic, to Novo Nordisk for a total of $200 million. Under the deal, which is expected to close by Dec. 30, Novo will get its hands on the production site, support buildings and the plant’s entire existing workforce, which stands at ar

263

263

PharmaVoice

DECEMBER 4, 2024

Dr. Marty Makary’s conflicts of interest could come into question before he is confirmed as the next FDA commissioner.

FDA 105

FDA 105

Fierce Pharma

DECEMBER 4, 2024

Following its endorsement of Eli Lilly’s obesity medicine tirzepatide, England’s National Institute for Health and Care Excellence (NICE) has laid out plans for an unprecedented phased rollout that | Roughly 220,000 people in England will be eligible for the drug during the three-year launch phase. Afterward, officials plan to open access to a wider group of obesity patients, which numbers in the millions in England.

Patients 173

Patients Medicine 173

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patients

pharmaphorum

DECEMBER 4, 2024

Applied Therapeutics gets a warning letter from the FDA over a trial of rare disease drug govorestat, which was rejected by the agency last week

FDA 105

FDA 105

MedCity News

DECEMBER 4, 2024

In response to emailed questions, the founders of MucoLife Therapeutics shared their company’s approach, which is designed to help people with COPD, cystic fibrosis, asthma, and pulmonary fibrosis. The post A Biotech Startup’s Quest to Relieve Pulmonary Mucus Obstruction for Respiratory Care appeared first on MedCity News.

Biopharma 116

Biopharma 116

pharmaphorum

DECEMBER 4, 2024

The UKHSA has taken steps to prepare for a possible bird flu outbreak by placing an order with Seqirus for millions of H5 vaccine doses

98

98

PharmaTimes

DECEMBER 4, 2024

Data highlights effectiveness of EVER001 in treating pMN

97

97

Advertisement

Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten

Sales

pharmaphorum

DECEMBER 4, 2024

Eli Lilly's Zepbound beats Novo Nordisk's Wegovy in the first head-to-head trial comparing the two obesity drugs.

94

94

PharmaVoice

DECEMBER 4, 2024

Four companies that refreshed their mission and public persona with a new look.

Biopharma 90

Biopharma 90

PharmaTimes

DECEMBER 4, 2024

Versant Ventures leads investment round to advance drug

Leads 84

Leads 84

pharmaphorum

DECEMBER 4, 2024

The MHRA isn't sufficiently funded to meet its obligations and that could threaten UK investment in life sciences, according to an ABPI report

Pharma 74

Pharma 74

Advertisement

PharmaTech

DECEMBER 4, 2024

The European Commission has developed a roadmap aimed at reversing the rising trend of cancer across the European Union.

69

69

Pharma Marketing Network

DECEMBER 4, 2024

Table of Contents Sr# Headings 1 Introduction 2 Digital Transformation in Pharma Marketing 3 Patient-Centric Marketing 4 Personalized Healthcare Campaigns 5 The Role of AI and Machine Learning 6 Leveraging Social Media Platforms 7 Data-Driven Decision Making 8 Omnichannel Marketing Strategies 9 The Power of Influencer Marketing 10 Navigating Regulatory Challenges 11 Sustainability in Pharma Marketing 12 Conclusion 13 FAQs Introduction Pharma marketing is undergoing a revolution.

Marketing 52

Marketing Pharma Media Education 52

PharmaTech

DECEMBER 4, 2024

The agency’s safety committee found no sufficient evidence of causal relationship between the antibiotic doxycycline and the risk of suicide or suicidal thoughts.

Safety 69

Safety 69

European Pharmaceutical Review

DECEMBER 4, 2024

A new report, ‘ Enhancing the role of UK medicine regulation ’ by the Association of the British Pharmaceutical Industry (ABPI) explores the key role that regulatory excellence has in driving innovation and early treatment access for patients, as well bringing investment into the UK. It provides key recommendations aimed at rebuilding the UK’s world-class reputation in regulatory science, medicines’ development and licensing, driving economic growth, ensuring earlier patient access to innovative

Competition 52

Competition Medicine Leads Pharmaceutical 52

Advertisement

Quotas need to be hit. Revenue goals need to be met. This reality makes shortening sales onboarding time a top priority. Organizations with a standard onboarding process boost employee retention by 58% and increase productivity by 50%. Unfortunately, many companies struggle with inefficient processes that lead to high turnover and missed revenue opportunities.

Sales

Pharmaceutical Technology

DECEMBER 4, 2024

An open-label Phase III trial showed that participants using Zepbound saw 47% greater relative weight loss compared to Wegovy.

59

59

Spotio

DECEMBER 4, 2024

Sales intelligence tools have become essential for modern sales teams. In 2025, your success will depend on your ability to collect and analyze critical data. Whether your goal is to boost productivity, enhance decision-making, or drive sustainable growth, the right sales intelligence tool can be a game-changer. The sales intelligence industry is projected to reach $8.25 billion by 2033, highlighting the growing importance of these solutions.

Sales 52

Sales Prospecting Leads B2B Sales 52

Pharmaceutical Technology

DECEMBER 4, 2024

US police have confirmed that Brian Thompson was fatally shot outside an investor conference by a masked assailant.

59

59

Pharma Marketing Network

DECEMBER 4, 2024

Table of Contents Sr# Headings 1 Introduction 2 Understanding the Challenges in Marketing Pharma 3 Why Digital Transformation is Essential 4 Patient-Centric Marketing: Building Trust 5 Harnessing the Power of Omnichannel Marketing 6 Data-Driven Insights for Targeted Campaigns 7 Social Media in Pharma Marketing: Opportunities and Risks 8 AI and Automation: The Future of Marketing Pharma 9 Branded Content: Educate, Don’t Just Promote 10 Navigating Regulatory Hurdles 11 Sustainability: A Growing De

Competition 52

Competition Marketing Pharma Media 52

Advertisement

Distribution

Pharmaceutical Technology

DECEMBER 4, 2024

Maze Therapeutics has completed a Series D financing round, raising $115m to propel the development of its lead candidates, MZE829 and MZE782.

Leads 59

Leads 59

Pharmaceutical Commerce

DECEMBER 4, 2024

In the first part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Joe Lipari, director of product management, Systech, describes the latest state of DSCSA implementation guidelines.

Pharma 52

Pharma Management 52

Pharmaceutical Technology

DECEMBER 4, 2024

Ipsen has entered an exclusive worldwide licensing agreement with Biomunex Pharmaceuticals to develop BMX-502.

Pharmaceutical 59

Pharmaceutical 59

Pharmaceutical Commerce

DECEMBER 4, 2024

A qualitative analysis consisting of patients, care partners, and oncology clinicians measures the sources of time burdens, along with how these impact various individuals.

Patients 52

Patients 52

Advertisement

Are your sellers unsure about using AI in their day-to-day workflows? Or are they eager to try but uncertain where to start? They might be asking: Which tasks are best suited for AI? How will using AI affect my relationship with my customers? With so many tools available, which ones are the most useful to me? To help answer these and other common questions about using AI during the sales cycle, we surveyed B2B sellers who were early adopters to get their insight and advice about how to use gen A

Sales